These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Pulmonary hypertension related to thalidomide therapy in refractory multiple myeloma. Antonioli E; Nozzoli C; Gianfaldoni G; Mannelli F; Rossi S; Betti S; Bernardeschi P; Fiorentini G; Bosi A Ann Oncol; 2005 Nov; 16(11):1849-50. PubMed ID: 16012178 [No Abstract] [Full Text] [Related]
15. Efficacy and safety of thalidomide in the treatment of multiple myeloma. Warzocha K; Kraj M; Pogłód R; Szpila T; Mendek-Czajkowska E; Chełstowska M; Tronina RH Acta Pol Pharm; 2008; 65(6):771-4. PubMed ID: 19172865 [No Abstract] [Full Text] [Related]
16. [Thalidomide for the treatment of refractory multiple myeloma]. Kakimoto T; Hattori Y; Okamoto S Rinsho Ketsueki; 2002 May; 43(5):345-8. PubMed ID: 12096483 [No Abstract] [Full Text] [Related]
17. [Thalidomide and others: new treatment for myeloma]. Malphettes M; Fermand JP Rev Prat; 2003 Oct; 53(15):1633-5. PubMed ID: 14689905 [No Abstract] [Full Text] [Related]
18. Encephalopathy in a patient after long-term treatment with thalidomide. Sohlbach K; Heinze S; Shiratori K; Sure U; Pagenstecher A; Neubauer A J Clin Oncol; 2006 Oct; 24(30):4942-4. PubMed ID: 17050881 [No Abstract] [Full Text] [Related]
19. Thalidomide-associated arterial thrombosis: two case reports. Altintas A; Ayyildiz O; Atay AE; Cil T; Isikdogan A; Muftuoglu E Ann Acad Med Singap; 2007 Apr; 36(4):304-6. PubMed ID: 17483863 [No Abstract] [Full Text] [Related]